How Sonali Bloom is Redefining Clinical Trials in Healthcare
Sonali Bloom, the CEO of 20/20 Onsite, is pioneering a transformation in healthcare through her innovative approach to decentralised clinical trials. She leads the company’s vision of making essential ophthalmic assessments more accessible by using state-of-the-art mobile vision clinics. These mobile clinics allow 20/20 Onsite to bring eye care directly to patients at workplaces, schools, neighbourhoods, and clinical research sites. Bloom’s approach bridges significant gaps in healthcare access, especially for clinical trials, where her team ensures that high-quality eye assessments reach those who might otherwise have limited access.
Her recent Platinum Award for CEO of the Year at the 2024 TITAN Women in Business Awards recognizes her groundbreaking work in this space. Under her leadership, 20/20 Onsite has become a trusted partner for life sciences companies by enabling point-of-need services that streamline clinical trials and improve outcomes. Bloom’s forward-thinking strategies not only address pressing healthcare challenges but also set new standards for patient-centered care in the industry. Her success exemplifies how innovation and commitment can redefine healthcare delivery, bringing critical services closer to those in need.
Post Comment